CA1340898C - Anticorps monoclonaux anti-antigenes associes a des lymphomes; lignees de cellules hybrides produisant ces anticorps; leur utilisation - Google Patents
Anticorps monoclonaux anti-antigenes associes a des lymphomes; lignees de cellules hybrides produisant ces anticorps; leur utilisationInfo
- Publication number
- CA1340898C CA1340898C CA 564987 CA564987A CA1340898C CA 1340898 C CA1340898 C CA 1340898C CA 564987 CA564987 CA 564987 CA 564987 A CA564987 A CA 564987A CA 1340898 C CA1340898 C CA 1340898C
- Authority
- CA
- Canada
- Prior art keywords
- atcc
- antibody
- canine
- lymphoma
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3061—Blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4428587A | 1987-04-30 | 1987-04-30 | |
| US044,285 | 1987-04-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1340898C true CA1340898C (fr) | 2000-02-15 |
Family
ID=21931514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 564987 Expired - Fee Related CA1340898C (fr) | 1987-04-30 | 1988-04-25 | Anticorps monoclonaux anti-antigenes associes a des lymphomes; lignees de cellules hybrides produisant ces anticorps; leur utilisation |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP0289053A3 (fr) |
| CA (1) | CA1340898C (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017151000A1 (fr) | 2016-03-02 | 2017-09-08 | Instytut Immunologii I Terapii Doświadczalnej Polskiej Akademii Nauk | Anticorps monoclonaux qui reconnaissent spécifiquement l'antigène dal-dr canin et leurs utilisations |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU632843B2 (en) * | 1989-08-10 | 1993-01-14 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Cat-mouse heterohybridoma and gene fragment coding for constant region of feline immunoglobulin |
| AU640397B2 (en) * | 1989-08-25 | 1993-08-26 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Dog-mouse heterohybridoma and gene fragment coding for constant region of canine immunoglobulin |
-
1988
- 1988-04-25 CA CA 564987 patent/CA1340898C/fr not_active Expired - Fee Related
- 1988-04-29 EP EP88106938A patent/EP0289053A3/fr not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017151000A1 (fr) | 2016-03-02 | 2017-09-08 | Instytut Immunologii I Terapii Doświadczalnej Polskiej Akademii Nauk | Anticorps monoclonaux qui reconnaissent spécifiquement l'antigène dal-dr canin et leurs utilisations |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0289053A2 (fr) | 1988-11-02 |
| EP0289053A3 (fr) | 1989-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3095175B2 (ja) | B細胞リンパ腫の治療のためのヒトbリンパ球限定分化抗原に対するキメラ抗体と放射能標識抗体の療法利用 | |
| KR100365632B1 (ko) | 인간b임파구제한분화항원에대한키메릭및방사선표지화된항체의b세포임파종치료를위한치료학적응용 | |
| CA1319899C (fr) | Anticorps monoclonaux des recepteurs du fragment fc de l'immunoglobuline g des mononucleaires phagocytes | |
| EP0285059B1 (fr) | Anticorps monoclonaux contre des antigènes glycolipides et leur utilisation | |
| RU2658438C2 (ru) | Химерное терапевтическое антитело нн1 против cd-37 | |
| RU2177805C2 (ru) | Средство, применяемое при лечении опухолей лимфатической ткани | |
| DE69033631T2 (de) | Therapeutische verwendungen der hypervariablen region des monoklonalen antikörpers m195 und konstrukte davon | |
| JPH05504330A (ja) | ヒトのがん腫と反応する新しい抗体 | |
| JPH11506435A (ja) | 腫瘍特異的抗体を利用する大腸ガンの治療方法 | |
| CN101678101B (zh) | 可用于诊断和治疗b细胞慢性淋巴细胞白血病的能够在肿瘤细胞中诱导凋亡的药物组合物 | |
| CA2761885A1 (fr) | Procedes et compositions pour traiter un lupus | |
| US6007814A (en) | Therapeutic uses of the hypervariable region of monoclonal antibody M195 and constructs thereof | |
| JPH06501705A (ja) | 抗−腫瘍抗体及び生物学的活性剤の組合せによる相乗治療 | |
| Heijnen et al. | Generation of HER-2/neu-specific cytotoxic neutrophils in vivo: efficient arming of neutrophils by combined administration of granulocyte colony-stimulating factor and Fcgamma receptor I bispecific antibodies | |
| US5084391A (en) | Monoclonal antibody to the interleukin-2-receptor and its use | |
| CA3211203A1 (fr) | Methodes et materiaux pour le traitement d'expansions de cellules t clonales | |
| CA1340898C (fr) | Anticorps monoclonaux anti-antigenes associes a des lymphomes; lignees de cellules hybrides produisant ces anticorps; leur utilisation | |
| JP2000509015A (ja) | T細胞及びb細胞リンパ腫及び白血病の治療のためのcd48に対する抗体の使用 | |
| US5169775A (en) | Monoclonal antibodies against lymphoma-associated antigens, hybrid cell lines producing these antibodies | |
| US5100378A (en) | Enhancement of target cell localization of lymphoid cells | |
| EP0445078B1 (fr) | Nouvelle utilisation d'un anticorps monoclonal | |
| JPH01502195A (ja) | 細胞毒性結合物の増強法 | |
| WO1997030173A1 (fr) | Anticorps monoclonal reconnaissant les antigenes presents a la surface des cellules endotheliales d'un vaisseau tumoral | |
| PT100568A (pt) | Anticorpos monoclonais e antigeneos para o melanoma humano | |
| CN103041387B (zh) | 恶性b细胞淋巴瘤抗体药物的新用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |